Our investigation of UnitedHealth, explainer on Oropouche and news on maternal health
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
Category: Medicine
STAT+: UnitedHealth pledged a hands-off approach after buying a Connecticut medical group. Then it upended how doctors practice
MIDDLETOWN, Conn. — UnitedHealth Group told the Connecticut primary care doctors everything they wanted to…
NIH launches $270 million anti-overdose research program for, and led by, Native Americans
Fatal drug overdoses shot up during the peak of Covid-19 in 2020. And as the…
Opinion: Medicare’s new transitional coverage of emerging technologies program doesn’t go far enough
Included in the original law that established Medicare in 1965 was a short but consequential…
21 cases of little-known Oropouche virus detected in U.S.
Nearly two dozen people in the United States have been confirmed to have contracted the…
STAT+: Centene eliminates brokers’ commissions for Medicare drug plans
Health insurer Centene will not pay any commissions to brokers and agents who help people…
STAT+: Pharmalittle: We’re reading about Lilly cutting Zepbound’s price; Pfizer selling direct to consumers, and more
Good morning, everyone, and how are you today? We are just fine, thank you, especially…
Pfizer and Lilly want to sell you drugs directly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Glucose monitors, mpox vaccine inequity and effects of LGBTQ+ restrictions
STAT’s coverage of chronic health issues is supported by a grant from Bloomberg Philanthropies. Our financial…
STAT+: Lilly launches Zepbound vials in move that could ease supply constraints
Eli Lilly said Tuesday that it will start providing low-dose vials of its obesity drug…
STAT+: To help migraine patients — and sell more medicines — major drugmakers turn to telehealth
In 2021, Katey Frederking had reached the end of her rope. The 29-year-old was struggling…
Opinion: To stop mpox from becoming the next pandemic, we must address global vaccine inequities
In early 2022, I cared for one of the first patients with mpox in Massachusetts….
Opinion: The importance of reducing the financial burden of participating in clinical trials
Scientific advancements have helped millions of people living with cancer, heart disease, arthritis, obesity, and…
WHO launches plan to stanch mpox transmission and says the virus can be stopped
The U.N. health agency on Monday launched a six-month plan to help stanch outbreaks of…
A virus bodega, DNC takeaways, and free Covid tests
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
A Galapagos investor signals impatience with its turnaround efforts
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Continuous glucose monitoring for the masses is here. Are we ready for it?
NEW YORK — Glucose tracking is the future, Dexcom executives gushed at a glitzy launch…
STAT+: Pharmalittle: UCB selling a Chinese business, Tome layoffs, and more
Happy Monday, Pharmalittle family. Adam Feuerstein here, once again filling in for Ed. I have…
STAT+: Biden administration’s $3.2 billion antiviral pandemic plan is fizzling out
NEW YORK — Sixteen floors above Central Park, Kris White keeps his gentler pathogens behind…
Opinion: Why Harvard, Penn, and Columbia have turned to M.D.s for leadership in troubled times
Recently, Columbia University’s president resigned after months of chaos, following in the footsteps of Harvard…
Opinion: Who should get to see the neurologist first: the sick or the at-risk?
Once a year, Jessi Keavney goes to see her neurologist. During the visit, the doctor asks if…
What you need to know about West Nile virus
News that Anthony Fauci, long-time former head of the National Institute of Allergy and Infectious…
Fauci recovering at home following hospitalization for West Nile virus infection
Anthony Fauci, former head of the National Institute of Allergy and Infectious Diseases, is recovering…
Opinion: STAT readers on mask bans, cancer screening, and empathy and AI
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences…
.jpg)
STAT+: Tome Biosciences files notice to lay off nearly entire staff
High-profile gene editing startup Tome Biosciences said in a legal filing Friday that it will…
STAT+: U.S. agency slaps down a J&J plan to switch payments for 340B hospitals
A U.S. government agency said that a planned move by Johnson & Johnson to alter…
STAT+: Pharmalittle: We’re reading about AstraZeneca threatening the U.K., mpox vaccine distribution, and more
And so, another working week will soon draw to a close. Not a moment too…
FDA approves latest Covid vaccines, and Harris makes her case
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
STAT+: Takeaways from the DNC on the health care fights ahead
WASHINGTON — The Democrats were not subtle this week about what their health care priorities are…
Settlement blocks diagnostics maker EpicGenetics from selling two questionable blood tests
A diagnostics company has agreed to stop selling two questionable blood tests as part of…
STAT+: AI in medicine: A national registry could help increase transparency, experts say
The use of artificial intelligence in hospitals is ramping up so fast — and with…
Opinion: A harm-reduction approach to eating out
Several years ago, while on a road trip, I ordered the now-discontinued spaghetti and meatballs…
Opinion: Why you may not need a checkup every year
I’m a doctor and epidemiologist, so you might expect me to be religious about preventative…
.jpg)
Listen: BioMarin’s executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion’s AI bona fides
What does the hiring of a well-known industry dealmaker mean for the future of BioMarin…
FDA approves updated Covid-19 vaccines, shots should be available in days
WASHINGTON — U.S. regulators approved updated Covid-19 vaccines on Thursday, shots designed to more closely target recent…
Columbia medical school gets $400 million gift to fund risky basic research
Columbia University announced Thursday that its medical school has received $400 million to fund a…
STAT+: Tome Biosciences, once a high-flying gene-editing startup, is floundering
Buzzy gene-editing startup Tome Biosciences is floundering, just nine months after launching with $213 million…
STAT+: Pharmalittle: We’re reading about a negative U.K. review of Leqembi, Bavarian Nordic’s strong earnings, and more
Good morning, Pharmalittle fans! Adam Feuerstein here, filling in for Ed. I drink my morning…
Oprah, Walz and other Democrats hammer reproductive freedom message at DNC
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: U.K.’s cost-effectiveness agency gives negative review of Alzheimer’s drug Leqembi
LONDON — Leqembi, the Alzheimer’s treatment from Eisai and Biogen, has hit another roadblock reaching…
STAT+: Digital therapeutics pioneer Pear’s treatments get a second life, a year after bankruptcy
Over a year after Pear Therapeutics filed for bankruptcy and shut down, its smartphone apps…
STAT+: Gene therapy pioneer Jim Wilson believes he can commercialize rare-disease drugs in a tough climate
If you’d told Jim Wilson three years ago that he’d be stepping down as director…
Opinion: In drug development, diversity must be extended to preclinical research
The pharmaceutical industry has long operated on a one-size-fits-all model, developing drugs primarily tested on,…
Alzheimer’s drug may raise the risk of brain bleed in patients with Down syndrome
A year ago, after much fanfare and controversy, the Food and Drug Administration approved Eisai…
Merck Ebola vaccine Ervebo shown to offer substantial protection
Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the…
Long Covid symptoms in kids aren’t one-size-fits-all, study shows
Rachel Gross wants to clear up misconceptions about children and Covid-19. A pediatrician and population…
STAT+: Pharmalittle: We’re reading about obesity drugs and suicidal thoughts, a FDA official’s conflicts, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
There’s a knowledge gap about miscarriages in the U.S., and researchers hope to close it
Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her…
Opinion: Doing more cancer screening won’t reduce Black-white health disparities
For years, Black Americans have been more likely to die of cancer than white Americans….
STAT+: Federal judge blocks noncompete ban, and FTC considers appeal
A federal judge in Texas appointed by former President Donald Trump has officially spiked the…